In the future, experimental animal models or human iPSC models may be utilized to study the mechanism of the miR-302-3p/SDC-1 axis in the pathogenesis of AF, and it may serve as a potential therapeutic target in the treatment of AF patients. The gene discussed is SDC1; the disease is atrial fibrillation.